Quote | Roivant Sciences Ltd. (NASDAQ:ROIV)
Last: | $10.48 |
---|---|
Change Percent: | -0.76% |
Open: | $10.66 |
Close: | $10.56 |
High: | $10.68 |
Low: | $10.45 |
Volume: | 2,350,156 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Roivant Sciences Ltd. (NASDAQ:ROIV)
2024-06-11 00:24:03 ET Summary Baker Brothers' 13F portfolio value decreased from $8.79B to $7.97B. The largest five stakes in the portfolio are Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Rhythm Pharma. Baker Brothers has had successful investments in companies that ...
2024-06-07 18:26:03 ET Summary The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Biotechs CRISPR Therapeutics, Voyager Therapeutics, and Alnylam Pharmaceuticals are covered along with Enovix, Uranium Royalty, Clover Health, a...
Message Board Posts | Roivant Sciences Ltd. (NASDAQ:ROIV)
Subject | By | Source | When |
---|---|---|---|
Vivek is going postal on ESG. | TooFrank | investorshub | 05/13/2022 4:32:37 AM |
MERRY CHRISTMAS , Roivant Sciences Ltd ($ROIV) | mick | investorshub | 12/24/2021 1:06:12 AM |
$ROIV progressing nicely since that initial dip to $6. | aries4747 | investorshub | 12/23/2021 11:24:45 PM |
Roivant Sciences Ltd ($ROIV) | mick | investorshub | 12/20/2021 8:47:42 PM |
https://www.otcmarkets.com/stock/$ROIV/disclosure | mick | investorshub | 12/20/2021 6:28:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 30, 2024, to report its financial results for the fourth quarter and fiscal year ended March 31...